Preserved pituitary response under ovarian stimulation with HMG and GnRH antagonists (Cetrorelix) in women with tubal infertility

scientific article published on 01 August 1995

Preserved pituitary response under ovarian stimulation with HMG and GnRH antagonists (Cetrorelix) in women with tubal infertility is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/0301-2115(95)02138-W
P698PubMed publication ID7556837

P2093author name stringT Reissmann
K Diedrich
W Küpker
C Diedrich
O Bauer
R E Felberbaum
S al Hasani
P433issue2
P304page(s)151-155
P577publication date1995-08-01
P1433published inEuropean Journal of Obstetrics Gynecology and Reproductive BiologyQ15755730
P1476titlePreserved pituitary response under ovarian stimulation with HMG and GnRH antagonists (Cetrorelix) in women with tubal infertility
P478volume61

Reverse relations

cites work (P2860)
Q92308887Administration effects of single-dose GnRH agonist for luteal support in females undertaking IVF/ICSI cycles: A meta-analysis of randomized controlled trials
Q35165328An overview of GnRH antagonists in infertility treatments. Introduction
Q34034016Clinical application of GnRH-antagonists
Q43957485Comparison of GnRH agonists and antagonists in unselected IVF/ICSI patients treated with different controlled ovarian hyperstimulation protocols: a matched study
Q50723279Comparison of cryopreservation outcome with human pronuclear stage oocytes obtained by the GnRH antagonist, cetrorelix, and GnRH agonists.
Q36271008Effect of in vivo GnRH agonist and GnRH antagonist on hCG and insulin-stimulated progesterone production by human granulosa-lutein cells in vitro
Q44131161Effectiveness of an antagonist to gonadotrophin releasing hormone on the FSH and LH response to GnRH in perifused equine pituitary cells, and in seasonally acyclic mares
Q36094997Extrapituitary effects of GnRH antagonists in assisted reproduction: a review
Q34573314GnRH-antagonists in ovarian stimulation for IVF in patients with poor response to gonadotrophins, polycystic ovary syndrome, and risk of ovarian hyperstimulation: a meta-analysis
Q35049420Gonadotrophin-releasing hormone (GnRH) and GnRH agonists: mechanisms of action.
Q24245006Gonadotrophin-releasing hormone antagonists for assisted conception
Q33284961Gonadotrophin-releasing hormone antagonists for assisted conception: a Cochrane review
Q24185849Gonadotrophin-releasing hormone antagonists for assisted reproductive technology
Q24234608Gonadotrophin-releasing hormone antagonists for assisted reproductive technology
Q40601455Gonadotrophin-releasing hormone antagonists: will they replace the agonists?
Q24234765Gonadotropin-releasing hormone agonist versus HCG for oocyte triggering in antagonist assisted reproductive technology cycles
Q24236630Gonadotropin-releasing hormone agonist versus HCG for oocyte triggering in antagonist assisted reproductive technology cycles
Q24241061Gonadotropin-releasing hormone agonist versus HCG for oocyte triggering in antagonist assisted reproductive technology cycles
Q24193015Gonadotropin-releasing hormone agonist versus HCG for oocyte triggering in antagonist-assisted reproductive technology
Q43672714Gonadotropin-releasing hormone antagonist protocol: a novel method of ovarian stimulation in poor responders
Q34457474Gonadotropin-releasing-hormone-receptor antagonists
Q49017837Hormone profiles under ovarian stimulation with human menopausal gonadotropin (hMG) and concomitant administration of the gonadotropin releasing hormone (GnRH)-antagonist Cetrorelix at different dosages
Q34683548Impact of ovarian stimulation on corpus luteum function and embryonic implantation
Q35690393Impact of whole systems traditional Chinese medicine on in-vitro fertilization outcomes
Q36984419Investigation of pregnancy outcome and ovarian hyper stimulation syndrome prevention in agonist and antagonist gonadotropin-releasing hormone protocol
Q33944146Kisspeptin-54 triggers egg maturation in women undergoing in vitro fertilization
Q50644764Luteal hormonal profile of oocyte donors stimulated with a GnRH antagonist compared with natural cycles.
Q37022412The effectiveness of earlier oocyte retrieval in the case of a premature luteinizing hormone surge on hCG day in in vitro fertilization-embryo transfer cycles
Q35049436The luteal phase after ovarian stimulation.
Q35049429The role of GnRH antagonists in assisted reproduction.
Q54622516The role of LHRH agonists and antagonists.
Q24816913The role of aromatase inhibitors in ameliorating deleterious effects of ovarian stimulation on outcome of infertility treatment
Q36093450Use of antagonists in ovarian stimulation protocols
Q88990640What should be the protocol selection after failure of in-vitro fertilization at normoresponder patients: Agonist or antagonist?

Search more.